Immunome, Inc. (IMNM)

21.96 -0.18 (-0.81%) USD  |  NASDAQ  |  Feb 26, 15:54
More

Immunome Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for IMNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Prelude Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Relay Therapeutics, Inc. Upgrade
Context Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade